Who invested in Graphite Bio?
Graphite Bio's investors include RA Capital Management, Fidelity, Perceptive Advisors, Janus Henderson Investors and Cormorant Asset Management.
Who invested in Graphite Bio
Funding summaryUpdated 26 Oct 2026
$151Mraised across 1 round since 2021, from 1 source
- Latest round
- Series B, $151MMar 2021
- Investors
- 5
The rounds
- Mar 2021Series B$151M
Source recordedSEC filing: $151M sold, first sale Mar 2021
Founders and team
From Graphite Bio's own website: 1 founder, 15 on the team.
James McCollumFounder
- Eef SchimmelpenninkPresident and Chief Executive Officer
- Evert SchimmelpenninkPresident and Chief Executive Officer
- Ahmad ChaudhriVice President, Commercial Operations
- David ChoromanskiVice President, Marketing
- Domenick PorfidiaVice President, Sales
- Ethan MengleVice President of Medical Affairs
- Jaime ElledgeVice President, AI Enablement & Strategy
- Melody BurcarVice President, Finance
- Dan ChevallardChief Financial Officer
- Marc OdrichChief Medical Officer
- Shawn OlssonChief Commercial Officer
- Frederic GuerardBoard Member
- Jeff GeorgeChair
- Kimberlee C. DrapkinBoard Member
- Shelley ThunenBoard Member
Everyone who backed them
FidelityVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Graphite Bio
How much has Graphite Bio raised?
Graphite Bio has raised $151M across 1 round since 2021.
When did Graphite Bio last raise?
Graphite Bio's most recent round was a Series B of $151M in Mar 2021.
What was Graphite Bio's biggest round?
Its most recent round, $151M in Mar 2021, is also its largest on record.
Who backed Graphite Bio first?
Graphite Bio's first round on record, in Mar 2021, was backed by RA Capital Management, Fidelity and Perceptive Advisors and 2 others.
What stage is Graphite Bio at?
Graphite Bio's latest named round is a Series B, in Mar 2021.
Companies like Graphite Bio
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.